ACTUALITIES IN THROMBOEMBOLIC RISK MANAGEMENT IN THE PATIENTSWITH ATRIAL FIBRILLATION
Abstract:
The therapeutic management of the patients with atrial fibrillation should take into account the risk for thromboembolism, resulted in an incidence of strokes 5 times higher than in the general population. The stratification of this risk is validated by two scoring systems (CHADS2, CHA2DS2- VASc) which provide the ideal therapeutic option for each patient. Some controversies about the approach of thromboembolic risk in the latest Guide for the management of the patients with atrial fibrillation seem to have been resolved by the recent studies.
full text article in Romanian (.RO) |
full text article in English (.EN) |